Navigation Links
Vaccine May Prevent TB in People With HIV
Date:2/10/2010

Clinical trial results mark 'significant milestone,' expert says

TUESDAY, Feb. 9 (HealthDay News) -- A new vaccine prevents tuberculosis in people with HIV, a new study shows.

Phase III trials of 2,000 HIV-infected people in Tanzania found that the mycobacterium vaccae (MV) vaccine reduced the rate of definite tuberculosis (TB) by 39 percent. The findings have been published online in the journal AIDS.

TB is the most common cause of death among people in developing countries who have HIV/AIDS, and the results of the clinical trials are a "significant milestone," according to principal investigator Dr. Ford von Reyn, director of the DarDar International Programs for the infectious disease and international health section at Dartmouth Medical School, in Hanover, N.H.

"Since development of a new vaccine against tuberculosis is a major international health priority, especially for patients with HIV infection, we and our Tanzanian collaborators are very encouraged by the results," von Reyn said in a news release from the journal's publisher.

The next step, he said, involves improving manufacturing methods so that sufficient quantities of the MV vaccine can be produced for further studies and possible use in patients.

Because people newly infected with HIV risk contracting TB almost immediately, the researchers said, it's important that they get the MV vaccine before they begin taking antiretroviral drugs to fight the HIV infection.

More information

The American Lung Association has more about TB.



-- Robert Preidt



SOURCE: Lippincott Williams & Wilkins, news release, Feb. 2, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... and localization services for life science companies, has achieved ISO 17100:2015 certification ... SÜD America. ISO 17100 is the globally recognized standard that establishes guidance ...
(Date:1/23/2017)... ... January 23, 2017 , ... The iaedp Foundation, ... healthcare treatment providers who treat the full spectrum of eating disorder problems, proudly ... Presidents Council consists of the leading eating disorder treatments centers located throughout the ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... Sharon Kleyne, ... the air to educate listeners about the benefits of making new water infrastructure a ... Kleyne said, “it’s appropriate that we expect water infrastructure to become a top priority ...
(Date:1/23/2017)... ... 2017 , ... METTLER TOLEDO has announced the availability of ... PAT Tools . , Crystallization is a common step used during ... Chemists now spend more time developing better intermediate and final crystallization steps. ...
(Date:1/23/2017)... ... January 23, 2017 , ... "ProRandom is a set of camera tools that allow ... looks in Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... layers of text with video footage. ProRandom works by using a virtual camera to ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... -- ResMed (NYSE : RMD), BMC (Pékin, Chine) et 3B Medical ... se sont mis d,accord sur le règlement mondial de ... 3B seront autorisés à vendre leurs produits existants en ... effectuera le paiement de la décision en une seule ... entre les deux parties. Le règlement n,inclut pas l,admission ...
(Date:1/23/2017)... Spain , January 23, 2017 /PRNewswire/ ... biopharmaceutical company focused on treatments for calcification disorders, ... enrolled in the Phase IIb "CaLIPSO Study" clinical ... of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) patients ... in the last stage of chronic kidney disease, ...
(Date:1/23/2017)... InDex Pharmaceuticals Holding AB (publ) today announced ... of the European Crohn,s and Colitis Organisation (ECCO). The ECCO congress ... on inflammatory bowel disease (IBD). The congress is held in ... ... again having been selected to present data at the largest IBD ...
Breaking Medicine Technology: